Login to Your Account

IPO Queue Heats Up with Intercept Pharma Filing

By Marie Powers
Staff Writer

Thursday, September 6, 2012
Intercept Pharmaceuticals Inc. became the third biotech in three weeks to file an S-1 registration statement with the SEC for a proposed initial public offering (IPO), following Regulus Therapeutics Inc. and OvaScience Inc. into the queue.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription